Akums Drugs and Pharmaceuticals informs about updates

26 Nov 2024 Evaluate
Akums Drugs and Pharmaceuticals has informed that Maxcure Nutravedics (Maxcure), a wholly owned subsidiary of Akums Drugs and Pharmaceuticals (Akums) has entered into a Collaboration Agreement with Jagdale Industries (Jagdale). This collaboration exclusively focuses on aseptic manufacturing and subsequent filling in carton packing for the Ready-to-Drink (RTD) market, targeting an expansive array of health and wellness products.

The above information is a part of company’s filings submitted to BSE.


Akums Drugs & Pharma Share Price

443.95 0.20 (0.05%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×